Israeli companies that are not public face many issues – How can we obtain the capital we need to grow? Should we consider a strategic investment or distribution agreement with a larger company? How should we communicate with institutional investors and the public generally? This program will help you answer those questions. While the focus will be on med-tech, biotech, health care and other life science companies, the issues they face are similar to the issues confronting all private Israeli technology companies.
The program will feature the following speakers:
Questions the speakers will focus on include: